Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis
Posted on 2014-11-12 - 03:12
TND = target not detected; DET = HCV RNA detected; TND/TND = HCV not detected in both assays; TND/DET = HCV RNA detected by only one assay; DET/DET: HCV RNA detected by both assays. *Patients with unavailable virological treatment outcome were excluded from analysis.
CITE THIS COLLECTION
DataCite
3 Biotech
3D Printing in Medicine
3D Research
3D-Printed Materials and Systems
4OR
AAPG Bulletin
AAPS Open
AAPS PharmSciTech
Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg
ABI Technik (German)
Academic Medicine
Academic Pediatrics
Academic Psychiatry
Academic Questions
Academy of Management Discoveries
Academy of Management Journal
Academy of Management Learning and Education
Academy of Management Perspectives
Academy of Management Proceedings
Academy of Management Review
Maasoumy, Benjamin; Hunyady, Bela; Calvaruso, Vincenza; Makara, Mihály; Vermehren, Johannes; Haragh, Attila; et al. (2015). Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis. PLOS ONE. Collection. https://doi.org/10.1371/journal.pone.0110857
or
Select your citation style and then place your mouse over the citation text to select it.
SHARE
Usage metrics
Read the peer-reviewed publication
AUTHORS (13)
BM
Benjamin Maasoumy
BH
Bela Hunyady
VC
Vincenza Calvaruso
MM
Mihály Makara
JV
Johannes Vermehren
AH
Attila Haragh
SS
Simone Susser
BB
Birgit Bremer
GC
Gavin Cloherty
MP
Michael P. Manns
AC
Antonio Craxì
HW
Heiner Wedemeyer
CS
Christoph Sarrazin